Antiviral Protects Against CMV After Stem Cell Transplants – Medscape
|
Antiviral Protects Against CMV After Stem Cell Transplants
Medscape The results show a significant reduction in the incidence of CMV events (which includes CMV disease and detectable CMV levels in the blood) in HCT recipients who were treated with CMX001. These CMV events were reported by 10% of patients on the new … Novel Antiviral Blocks CMV After Stem Cell TxMedPage Today CMX001 reduced cytomegalovirus disease after HSCTHealio |
